InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,426.00
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.41
(
-0.20%
)
Bitcoin
64,315.83
(
0.07%
)
Post# of 2795
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 260
Posts 18197
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: puravida post# 2676

Thursday, 11/02/2017 8:47:54 AM

Thursday, November 02, 2017 8:47:54 AM

Post# of 2795
Agree if you mean acquisition by MNK for $1.52/share--MNK has had its own share of controversy of late. Is market anticipating a bidding war? I would think GILD, with its focus on hepatic disease in general, would be interested in OCRX.

http://ih.advfn.com/p.php?pid=nmona&article=75999661

We did not attend the Liver-related convention here in Washington many days ago for OCRX presentations.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up